Michael Fray is a Principal Scientist at Matchpoint Therapeutics, specializing in Gamma Delta T cell immunotherapies. Previously, Michael worked as a Senior Scientist at Takeda and has extensive experience in immunology, holding a Ph.D. in the field from Tufts University. Their research includes the investigation of T cell signaling dynamics and contributions to innovative immunotherapies, including patent development. Additionally, Michael has a background in IT, having served as a Senior Network Engineer for the Fort Mill School District, where they managed technology initiatives and teams.
This person is not in the org chart
This person is not in any teams
This person is not in any offices